Global Collaborative Research on Establishing a Korean Cognitive Aging Cohort

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorKorea University

About this trial

The goal of this observational study is to learn how daily emotional stress affects cognitive function and inflammation in community-dwelling older adults aged 60 and older in Seoul, Republic of Korea. The main questions it aims to answer are:

Does daily psychological stress measured in real-time affect short-term and long-term cognitive function in older adults? Do pro-inflammatory cytokines (such as CRP, IL-6, IL-10, and TNF-α) mediate the relationship between emotional stress and cognitive decline? How do social support and social isolation influence cognitive function and inflammatory biomarkers over time?

Participants will:

Complete baseline surveys assessing depression, cognitive function, and personal characteristics Use a smartphone app to answer brief surveys about their emotions, cognitive performance, and social interactions 1-6 times daily for two weeks Wear a Galaxy Watch to track sleep quality, heart rate, and physical activity Provide blood samples for inflammatory biomarker analysis Return for follow-up assessments at 6 months and 1 year

This study is part of an international collaboration to establish a Korean cohort comparable to the U.S. Einstein Aging Study, with the aim of developing culturally tailored dementia prevention strategies.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults aged 60 or older residing in the Republic of Korea

Samsung Galaxy smartphone users capable of using smartphone applications

Sufficient cognitive ability to understand and follow research instructions (MMSE score of 21 or above)

For individuals who do not meet the cognitive criteria, those who understand the study procedures and provide informed consent along with their legal guardian

Disqualifiers

Diagnosis of dementia at baseline

Severe visual or hearing impairments that prevent participation in psychological assessments

Illiteracy that prevents participation in cognitive testing

Less than 80% compliance with the 2-day preliminary EMA protocol (one additional attempt allowed after re-training)

Trial population

This study targets community-dwelling older adults aged 60 and older in Seoul, Republic of Korea. Participants are recruited from the Seongbuk Senior Welfare Center and Gangbuk Municipal Senior Welfare Center. Seongbuk-gu and Gangbuk-gu are districts with higher proportions of older adults and elevated chronic disease rates compared to other areas in Seoul, making them regions of interest for aging research. The study population includes older adults living independently in the community who utilize local senior welfare center services. By recruiting from these districts, the study aims to generate evidence for developing effective dementia prevention strategies applicable to community-based settings in Korea. Participants must be Samsung Galaxy smartphone users with sufficient cognitive ability to engage with ecological momentary assessment (EMA) protocols. Exclusions: dementia diagnosis, severe sensory impairments, or health conditions preventing participation.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

180 Participants
are grouped into 1 trial group
Group A: Community-Dwelling Older Adults in Seoul

Trial outcomes

Primary outcomes

1

Incident MCI and Dementia Diagnosis

Incident mild cognitive impairment (MCI) and dementia diagnoses will be identified through clinical diagnosis during the study periods and linkage with the National Health Insurance Service (NHIS) database in Korea. This administrative data linkage enables long-term tracking of cognitive outcomes beyond the active study period.

Time frame
baseline, 6-month, 1-year, 5-year and 10-year follow-up
2

SNSB-2 Composite Score

Composite score from the Seoul Neuropsychological Screening Battery-2 (SNSB-2), a standardized neuropsychological assessment covering attention, language, visuospatial function, memory, and executive function domains (Standardized composite z-score).

Time frame
Baseline and 12 months
3

Wechsler Memory Scale Score

Memory function assessed using the Wechsler Memory Scale (Index score (points)).

Time frame
Baseline, 6 months, and 12 months
4

Block Design Subtest Score

Visuospatial constructional ability assessed using the Block Design subtest from the Wechsler Adult Intelligence Scale (WAIS) in Scaled score (points).

Time frame
Baseline, 6 months, and 12 months

Secondary outcomes

1

EMA Daily Negative Affect

Daily negative emotional states measured via smartphone-based EMA surveys administered 1-6 times per day during the 2-week intensive period (0-100 scale).

Time frame
Daily during 2-week EMA period at baseline, 6 months, and 12 months
2

EMA Daily Positive Affect

Daily positive emotional states measured via smartphone-based EMA surveys administered 1-6 times per day during the 2-week intensive period. The scores are assessed by a mean score (0-100 scale).

Time frame
Daily during 2-week EMA period at baseline, 6 months, and 12 months
3

Depressive Symptoms

Depressive symptoms assessed using the Patient Health Questionnaire-9 (PHQ-9) at each follow-up visit. Yes/No coding will be used to assess reports of depressive symptoms.

Time frame
Baseline, 6 months, and 12 months
4

EMA Daily Social Interaction Frequency

Frequency of daily social interactions measured via smartphone-based EMA surveys during the 2-week intensive period. Unit of Measure: Number of interactions per day

Time frame
Daily during 2-week EMA period at baseline, 6 months, and 12 months

Other outcomes

1

Serum Cortisol Level

Cortisol level measured from serum samples using enzyme-linked immunosorbent assay (ELISA) (nmol/L).

Time frame
Baseline and 12 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Korea University

Lead sponsor

Korea University Anam Hospital

Collaborator

Penn State University

Collaborator

Albert Einstein College of Medicine

Collaborator